These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23443116)

  • 1. Biotransformations utilizing β-oxidation cycle reactions in the synthesis of natural compounds and medicines.
    Swizdor A; Panek A; Milecka-Tronina N; Kołek T
    Int J Mol Sci; 2012 Dec; 13(12):16514-43. PubMed ID: 23443116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
    Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
    Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductive biotransformations of organic compounds by cells or enzymes of yeast.
    Ward OP; Young CS
    Enzyme Microb Technol; 1990 Jul; 12(7):482-93. PubMed ID: 1366632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocatalytic ketone reduction--a powerful tool for the production of chiral alcohols-part II: whole-cell reductions.
    Goldberg K; Schroer K; Lütz S; Liese A
    Appl Microbiol Biotechnol; 2007 Aug; 76(2):249-55. PubMed ID: 17486338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.
    Liu L; Floreancig PE
    Curr Opin Drug Discov Devel; 2010; 13(6):733-47. PubMed ID: 21061234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementation of biotransformations with chemical C-H oxidation: copper-catalyzed oxidation of tertiary amines in complex pharmaceuticals.
    Genovino J; Lütz S; Sames D; Touré BB
    J Am Chem Soc; 2013 Aug; 135(33):12346-52. PubMed ID: 23875728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyunsaturated fatty acids, Part 2: Biotransformations and biotechnological applications.
    Gill I; Valivety R
    Trends Biotechnol; 1997 Nov; 15(11):470-8. PubMed ID: 9369030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial steroid transformations: current state and prospects.
    Donova MV; Egorova OV
    Appl Microbiol Biotechnol; 2012 Jun; 94(6):1423-47. PubMed ID: 22562163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective biotransformations of nitriles in organic synthesis.
    Wang MX
    Acc Chem Res; 2015 Mar; 48(3):602-11. PubMed ID: 25699471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytochrome P450 isoenzymes in metabolism of endo- and exogenic compounds].
    Wiśniewska A; Mazerska Z
    Postepy Biochem; 2009; 55(3):259-71. PubMed ID: 19928582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative biotransformations using oxygenases.
    Li Z; van Beilen JB; Duetz WA; Schmid A; de Raadt A; Griengl H; Witholt B
    Curr Opin Chem Biol; 2002 Apr; 6(2):136-44. PubMed ID: 12038996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon-carbon bond cleavage and formation reactions in drug metabolism and the role of metabolic enzymes.
    Bolleddula J; Chowdhury SK
    Drug Metab Rev; 2015; 47(4):534-57. PubMed ID: 26390887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the generation of chiral intermediates using enzymes.
    Davies HG; Green RH; Kelly DR; Roberts SM
    Crit Rev Biotechnol; 1990; 10(2):129-53. PubMed ID: 2202520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based interpretation of biotransformation pathways of amide-containing compounds in sludge-seeded bioreactors.
    Helbling DE; Hollender J; Kohler HP; Fenner K
    Environ Sci Technol; 2010 Sep; 44(17):6628-35. PubMed ID: 20690778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of metabolic patterns in teratogenic testing for food safety.
    Khera KS
    Clin Toxicol; 1976; 9(5):773-90. PubMed ID: 826367
    [No Abstract]   [Full Text] [Related]  

  • 16. Candida parapsilosis: A versatile biocatalyst for organic oxidation-reduction reactions.
    Chadha A; Venkataraman S; Preetha R; Padhi SK
    Bioorg Chem; 2016 Oct; 68():187-213. PubMed ID: 27544073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biotransformation of drugs. 1. Problems and general metabolic routes].
    Pfeifer S
    Pharmazie; 1968 May; 23(5):225-36. PubMed ID: 5717164
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotransformation and bioactivation reactions of alicyclic amines in drug molecules.
    Bolleddula J; DeMent K; Driscoll JP; Worboys P; Brassil PJ; Bourdet DL
    Drug Metab Rev; 2014 Aug; 46(3):379-419. PubMed ID: 24909234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper-Catalyzed Oxidative Carbon-Carbon and/or Carbon-Heteroatom Bond Formation with O
    Tang X; Wu W; Zeng W; Jiang H
    Acc Chem Res; 2018 May; 51(5):1092-1105. PubMed ID: 29648789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved product-per-glucose yields in P450-dependent propane biotransformations using engineered Escherichia coli.
    Fasan R; Crook NC; Peters MW; Meinhold P; Buelter T; Landwehr M; Cirino PC; Arnold FH
    Biotechnol Bioeng; 2011 Mar; 108(3):500-10. PubMed ID: 21246504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.